The prognosis for dental implants placed in patients taking oral bisphosphonates.
The success rate of dental implants placed in female patients taking oral bisphosphonates, before the risks became known in 2003, were compared with a control group of females receiving implants and not taking bisphosphonates. The bisphosphonate group had an overall success rate of 86 percent versus a success rate of 95 percent in the control group. This suggests that the failure rate of implants placed in patients taking oral bisphosphonates may be higher unless suggested safeguards are taken.
Kasai
Tadakatsu
T
Department of Oral and Maxillofacial Surgery, University of California, San Francisco 94143, USA.
Pogrel
M Anthony
MA
Hossaini
Mehran
M
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D019386:Alendronate / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016022:Case-Control Studies; D015921:Dental Implants; D019232:Dental Restoration Failure; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D016903:Drug Monitoring; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D016348:Osseointegration / Q000187:drug effects; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome
D050071:Bone Density Conservation Agents; D015921:Dental Implants; D004164:Diphosphonates; D019386:Alendronate